T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis Source: Eur Respir J 2011; 38: 1136-1144 Year: 2011
Expression of monocyte chemoattractant protein–1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008
Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD Source: Eur Respir J 2016; 47: 1093-1102 Year: 2016
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21 Source: Eur Respir J 2007; 29: 1082-1093 Year: 2007
IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma Source: Eur Respir J 2003; 22: 310-316 Year: 2003
Decreased T-bet expression and changes in levels of chemokines (IP-10, MIG, RANTES, MCP-1 and IL-8) in peripheral blood of adults with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 593s Year: 2006
Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 & CXCR2) gene expression in severe exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002
Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 and CXCR2) gene expression in severe exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003
Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 701-707 Year: 2005
The upregulation of CD-11B expression on circulating neutrophils by CXCL8 and the involvement of CXCR1 in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis Source: Eur Respir J 2009; 34: 676 Year: 2009
Monocyte derived microparticles upregulate IL-8, MCP-1, and ICAM-1 expression by human alveolar epithelial cells Source: Eur Respir J 2005; 26: Suppl. 49, 26s Year: 2005
Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015
Small neutralizing molecules to inhibit actions of the chemokine CXCL12 and other chemokines Source: Annual Congress 2010 - Models of airways disease Year: 2010
C-C chemokine receptor 2 gene polymorphism V64I and CCR2 expression on T lymphocytes in pulmonary sarcoidosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005
Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001
Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 17: 962-968 Year: 2001